Saonli Basu

Saonli Basu

Auto-generated profile, based on publicly available information

Saonli Basu

University of Minnesota

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2011 in Nature
Verified
Journal Article
Closed access
PDF file
CGChristian Gieger
Christian Gieger
ARAparna Radhakrishnan
Aparna Radhakrishnan
ACAna Cvejic
Ana Cvejic
WTWeihong Tang
Weihong Tang
EPEleonora Porcu
Eleonora Porcu
NSNicole Soranzo
Nicole Soranzo

30 March 2010 in Circulation
Verified
Journal Article
Closed access
PDF file
NSNicholas L. Smith
Nicholas L. Smith
MCMing-Huei Chen
Ming-Huei Chen
ADAbbas Dehghan
Abbas Dehghan
DSDavid P. Strachan
David P. Strachan
SBSaonli Basu
Saonli Basu
COChristopher J. O'Donnell
Christopher J. O'Donnell
Background— Plasma levels of coagulation factors VII (FVII), VIII (FVIII), and von Willebrand factor (vWF) influence risk of hemorrhage and thrombosis. We conducted genome-wide association studies to identify new loci associated with plasma levels. Methods and Results— The setting of the study included 5 community-based studies for discovery comprising 23 608 European-ancestry participants: Atherosclerosis Risk In Communities Study, Cardiovascular Health Study, British 1958 Birth Cohort, Framingham Heart Study, and Rotterdam Study. All subjects had genome-wide single-nucleotide polymorphism (SNP) scans and at least 1 phenotype measured: FVII activity/antigen, FVIII activity, and vWF antigen. Each study used its genotype data to impute to HapMap SNPs and independently conducted association analyses of hemostasis measures using an additive genetic model. Study findings were combined by meta-analysis. Replication was conducted in 7604 participants not in the discovery cohort. For FVII, 305 SNPs exceeded the genome-wide significance threshold of 5.0×10 −8 and comprised 5 loci on 5 chromosomes: 2p23 (smallest P value 6.2×10 −24 ), 4q25 (3.6×10 −12 ), 11q12 (2.0×10 −10 ), 13q34 (9.0×10 −259 ), and 20q11.2 (5.7×10 −37 ). Loci were within or near genes, including 4 new candidate genes and F7 (13q34). For vWF, 400 SNPs exceeded the threshold and marked 8 loci on 6 chromosomes: 6q24 (1.2×10 −22 ), 8p21 (1.3×10 −16 ), 9q34 (<5.0×10 −324 ), 12p13 (1.7×10 −32 ), 12q23 (7.3×10 −10 ), 12q24.3 (3.8×10 −11 ), 14q32 (2.3×10 −10 ), and 19p13.2 (1.3×10 −9 ). All loci were within genes, including 6 new candidate genes, as well as ABO (9q34) and VWF (12p13). For FVIII, 5 loci were identified and overlapped vWF findings. Nine of the 10 new findings were replicated. Conclusions— New genetic associations were discovered outside previously known biological pathways and may point to novel prevention and treatment targets of hemostasis disorders.

1 April 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MGMarine Germain
Marine Germain
DCDaniel I. Chasman
Daniel I. Chasman
HHHugoline de Haan
Hugoline de Haan
WTWeihong Tang
Weihong Tang
SLSara Lindström
Sara Lindström
PMPierre-Emmanuel Morange
Pierre-Emmanuel Morange

18 July 2011 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
SBSaonli Basu
Saonli Basu
WPWei Pan
Wei Pan

1 March 2016 in The American Journal of Medicine
Verified
Journal Article
Closed access
EBElizabeth J. Bell
Elizabeth J. Bell
PLPamela L. Lutsey
Pamela L. Lutsey
SBSaonli Basu
Saonli Basu
MCMary Cushman
Mary Cushman
SHSusan R. Heckbert
Susan R. Heckbert
AFAaron R. Folsom
Aaron R. Folsom

17 September 2013 in Circulation
Verified
Journal Article
Closed access
PDF file
MSMaria Sabater-Lleal
Maria Sabater-Lleal
JHJie Huang
Jie Huang
DCDaniel Chasman
Daniel Chasman
SNSilvia Naitza
Silvia Naitza
ADAbbas Dehghan
Abbas Dehghan
COChristopher J. O’dOnnell
Christopher J. O’dOnnell
Background—: Estimates of the heritability of plasma fibrinogen concentration, an established predictor of cardiovascular disease, range from 34% to 50%. Genetic variants so far identified by genome-wide association studies explain only a small proportion (90 000 subjects of European ancestry, the first genome-wide association meta-analysis of fibrinogen levels in 7 studies in blacks totaling 8289 samples, and a genome-wide association study in Hispanics totaling 1366 samples. Evaluation for association of single-nucleotide polymorphisms with clinical outcomes included a total of 40 695 cases and 85 582 controls for coronary artery disease, 4752 cases and 24 030 controls for stroke, and 3208 cases and 46 167 controls for venous thromboembolism. Overall, we identified 24 genome-wide significant ( P <5×10 −8 ) independent signals in 23 loci, including 15 novel associations, together accounting for 3.7% of plasma fibrinogen variation. Gene-set enrichment analysis highlighted key roles in fibrinogen regulation for the 3 structural fibrinogen genes and pathways related to inflammation, adipocytokines, and thyrotrophin-releasing hormone signaling. Whereas lead single-nucleotide polymorphisms in a few loci were significantly associated with coronary artery disease, the combined effect of all 24 fibrinogen-associated lead single-nucleotide polymorphisms was not significant for coronary artery disease, stroke, or venous thromboembolism. Conclusions—: We identify 23 robustly associated fibrinogen loci, 15 of which are new. Clinical outcome analysis of these loci does not support a causal relationship between circulating levels of fibrinogen and coronary artery disease, stroke, or venous thromboembolism.